ulevostinag (MK-1454)
intratumoral STING agonist in Ph. II for met. HNSCC cyclic dinucleotide derivative J. Med. Chem., March 25, 2022 Merck, Kenilworth, NJ
Molecules of the Month - March 2022
Molecules of the Month
- rilzabrutinib (PRN1008)
- INE963
- ulevostinag (MK-1454)
- compound 24
- compound 10
- etavopivat
- BMS-986176/LX-9211
- branaplam
- MAK683
- HR1405-01